Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.
Raphael NaccacheYounes BelkouchiLittisha LawranceBaya BenatsouJoya HadchitiPaul-Henry CournedeSamy AmmariHugues TalbotNathalie LassauPublished in: Cancers (2022)
AUC from DCE-US looks to be a promising new biomarker for fast, effective, and convenient immunotherapy response evaluation.